Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening

European Radiology, Feb 2018

Claudia I. Henschke, Mary Salvatore, Matthew Cham, Charles A. Powell, Larry DiFabrizio, Raja Flores, Andrew Kaufman, Corey Eber, Rowena Yip, David F. Yankelevitz, et al.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs00330-017-5234-9.pdf

Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening

Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening Claudia I. Henschke 0 1 2 Mary Salvatore 0 1 2 Matthew Cham 0 1 2 Charles A. Powell 0 1 2 Larry DiFabrizio 0 1 2 Raja Flores 0 1 2 Andrew Kaufman 0 1 2 Corey Eber 0 1 2 Rowena Yip 0 1 2 David F. Yankelevitz 0 1 2 0 Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 , USA 1 Department of Medicine, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 , USA 2 Department of Radiology, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, NY 10029 , USA ing the science and practice of image-based decision making. Dr. Yankelevitz also serves on the advisory board of GRAIL. Dr. Henschke is the President and serves on the board of the Early Diagnosis and Treatment Research Foundation. She receives no compensation from the Foundation. The Foundation is established to provide grants for projects, conferences, and public databases for research on early diagnosis and treatment of diseases. She is also an inventor of the patents and pending patents owned by Cornell Research Foundation (CRF). As of April 2009, she has divested herself of all royalties and other interests arising from these. Dr. Salvatore works for the Speakers Bureau for Genentech, specifically for interstitial lung disease. The other authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. - Compliance with ethical standards Conflict of interest Dr. Yankelevitz is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF), are non-exclusively licensed to General Electric. As an inventor of these patents, Dr. Yankelevitz is entitled to a share of any compensation which CRF may receive from its commercialization of these patents. He is also an equity owner in Accumetra, a privately held technology company committed to improv


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs00330-017-5234-9.pdf

Claudia I. Henschke, Mary Salvatore, Matthew Cham, Charles A. Powell, Larry DiFabrizio, Raja Flores, Andrew Kaufman, Corey Eber, Rowena Yip, David F. Yankelevitz, International Early Lung Cancer Action Program Investigators. Correction to: Baseline and annual repeat rounds of screening: implications for optimal regimens of screening, European Radiology, 2018, 1-1, DOI: 10.1007/s00330-017-5234-9